Effect of Battlefield Acupuncture on Pain Control During Inpatient Treatment of Exertional Rhabdomyolysis

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-99
SponsorTripler Army Medical Center

About this trial

Patients admitted with exertional rhabdomyolysis will be offered treatment with battlefield acupuncture for pain management and compared with patient's pain levels and pain medication requirements with those patients who declined battlefield acupuncture.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Rhabdomyolysis

chooses battlefield acupuncture

Disqualifiers

Greater than 72 hours from onset of symptoms

younger than 18 years of age

declines battlefield acupuncture

no pain

Trial design

Design model

Parallel

Treatments tested in this trial

  • Battlefield Acupuncture

    Procedure/Surgery

    Treatment of pain from rhabdomyolysis with battlefield acupuncture

Treatment groups

36 Participants
are divided into 2 treatment groups
Group A: Battlefield AcupunctureActive comparator 1 intervention
Group B: Patients admitted with rhabdomyolysis who did not receive battlefield acupunctureNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Pain Level on a pain scale of 0-10

Reported pain levels on a subjective pain score of 0-10

Time frame
Pain level will be measured through study completion (up to 12 months).
2

Pain Medication

Amount of pain medication required, Morphine equivalent and acetaminophen use on hospital days 1-7

Time frame
From enrollment to the end of treatment at 12 months

Secondary outcomes

1

Length of Hospital Stay in days

How long the patient stays in the hospital in days

Time frame
Length of time from admission to discharge in days (up to 7 days)

Other outcomes

Locations

1

Map coordinates are unavailable for these locations. Locations are shown below instead.

Tripler Army Medical CenterRecruiting96859, TAMC, HawaiiUnited StatesUnited States

Sponsors and contacts

Click on the lead sponsor to view all of their trials.